Girard Partners’s Globus Medical GMED Stock Holding History

Girard Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-150	Closed	-$8K	–	454
2018 Q3	$8K	Buy	+150	New	+$7.89K	﹤0.01%	776

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Girard Partners's GMED Position: Q4 2018 in Review

Girard Partners sold out of Globus Medical (GMED) in Q4 2018, closing a stake of 150 shares — an estimated $8K sold.

Girard Partners first reported a position in GMED in Q3 2018 and held it in 1 quarter. The position peaked at $8K in Q3 2018. 303 funds tracked by Wall St. Rank hold GMED as of Q4 2018.

Girard Partners reported no remaining Globus Medical position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 150 Globus Medical shares in Q4 2018, an estimated $8K.
Girard Partners first reported a position in Globus Medical in Q3 2018 and held it in 1 quarter.
Girard Partners's Globus Medical position peaked at $8K in Q3 2018.
303 funds tracked by Wall St. Rank held Globus Medical as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.